Integrative Medicine for the Improvement of Patient-Reported Outcomes, Values, and Experience

Inclusion Criteria

• Age >= 18 years or older
• Karnofsky score 60 or greater
• Life expectancy greater than six months
• English speaking
• HEAD AND NECK, THORACIC, GYNECOLOGIC, MELANOMA AND BREAST BASKETS: Patients with a diagnosis of head and neck tumors, thoracic tumors, gynecological tumors, melanoma, breast cancer, or gynecologic cancer
• HEAD AND NECK, THORACIC, GYNECOLOGIC, MELANOMA AND BREAST BASKETS: Actively receiving systemic oncological treatment or radiotherapy, or within 4 weeks of radiotherapy completion
• HEAD AND NECK, THORACIC, GYNECOLOGIC, MELANOMA AND BREAST BASKETS: Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale)
• FIRST REMISSION GYNECOLOGIC CANCER BASKET: Patients with a diagnosis of gynecologic malignancy who have completed definitive first line treatment (maintenance hormonal or targeted therapies are allowed). No evidence of progressive disease after definitive first line treatment
• ADVANCED CANCER BASKET: Patients with a diagnosis of stage III or IV lung cancer; any stage pancreatic cancer, unresectable cholangiocarcinoma, unresectable liver cancer, unresectable ampullary or peri-ampullary cancer, or other stage IV gastrointestinal cancer; stage III or IV ovarian or fallopian tube cancers or other stage IV gynecologic cancer; stage IV breast cancer; stage III testicular cancer or any stage IV genitourinary cancer; stage IV sarcoma; stage IV melanoma; stage IV endocrine cancer; lymphoma, myeloma, or Leukemia
• ADVANCED CANCER BASKET: Actively receiving oncological treatment, radiotherapy or active surveillance
• CANCER SURVIVOR BASKET: Patients with prior cancer diagnosis of any type or stage, who are free of oncological disease
• CANCER SURVIVOR BASKET: Completed active cancer treatment (e.g., surgery, radiation, chemotherapy [maintenance hormonal or targeted therapies are allowed])
• CANCER SURVIVOR BASKET: Worst fatigue over the last 7 days rated 4 or greater on (0-10 scale)

Exclusion Criteria

• Cognitive impairment that would preclude response to study assessments or require the use of Legally Authorized Representatives
• Unwilling to accept random assignment
• Concurrently enroll onto ongoing competing trials of integrative medicine interventions with symptom/toxicity as primary outcome. Note, however, patient will be allowed to enroll on other therapeutic protocols